• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Poor performance of FIB-4 in elderly individuals at risk for chronic liver disease - implications for the clinical utility of the EASL NIT guideline.

作者信息

van Kleef Laurens A, Sonneveld Milan J, de Man Robert A, de Knegt Robert J

机构信息

Department of Gastroenterology and Hepatology, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.

Department of Gastroenterology and Hepatology, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.

出版信息

J Hepatol. 2022 Jan;76(1):245-246. doi: 10.1016/j.jhep.2021.08.017. Epub 2021 Aug 28.

DOI:10.1016/j.jhep.2021.08.017
PMID:34461208
Abstract
摘要

相似文献

1
Poor performance of FIB-4 in elderly individuals at risk for chronic liver disease - implications for the clinical utility of the EASL NIT guideline.FIB-4在有慢性肝病风险的老年人中表现不佳——对欧洲肝脏研究学会（EASL）非侵入性检测（NIT）指南临床实用性的影响
J Hepatol. 2022 Jan;76(1):245-246. doi: 10.1016/j.jhep.2021.08.017. Epub 2021 Aug 28.
2
The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis.非酒精性脂肪性肝炎所致晚期纤维化患者的组织学和非侵入性检查与不良临床和患者报告结局的相关性。
Gastroenterology. 2021 Apr;160(5):1608-1619.e13. doi: 10.1053/j.gastro.2020.12.003. Epub 2020 Dec 8.
3
A new generation of non-invasive tests of liver fibrosis with improved accuracy in MASLD.新一代用于非酒精性脂肪性肝病（MASLD）的肝纤维化无创检测，其准确性有所提高。
J Hepatol. 2025 May;82(5):794-804. doi: 10.1016/j.jhep.2024.11.049. Epub 2024 Dec 13.
4
Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease.应用 ELF 试验、FIB-4 和 NAFLD 纤维化评分对人群进行肝病筛查。
J Hepatol. 2023 Aug;79(2):277-286. doi: 10.1016/j.jhep.2023.04.002. Epub 2023 Apr 21.
5
Diagnostic accuracy of FibroScan-AST (FAST) score, non-alcoholic fatty liver fibrosis score (NFS), FibroScan, and liver fibrosis index (FIB-4) for identifying fibrotic non-alcoholic steatohepatitis in patients with chronic hepatitis B with metabolic dysfunction-associated fatty liver disease.诊断准确性的 FibroScan-AST (FAST) 评分、非酒精性脂肪性肝纤维化评分 (NFS)、FibroScan 和肝纤维化指数 (FIB-4) 在识别代谢相关脂肪性肝病合并慢性乙型肝炎患者的纤维化非酒精性脂肪性肝炎。
Ann Med. 2024 Dec;56(1):2420858. doi: 10.1080/07853890.2024.2420858. Epub 2024 Oct 26.
6
Distribution of liver stiffness in non-alcoholic fatty liver disease with higher fibrosis-4 index than low cut-off index.肝纤维化 4 指数高于低截断指数的非酒精性脂肪性肝病患者的肝硬度分布。
J Gastroenterol Hepatol. 2019 Aug;34(8):1411-1416. doi: 10.1111/jgh.14559. Epub 2019 Jan 6.
7
The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.γ-谷氨酰转肽酶与血小板比值用于慢性乙型肝炎和非酒精性脂肪性肝病患者肝纤维化的无创评估
Oncotarget. 2017 Apr 25;8(17):28641-28649. doi: 10.18632/oncotarget.16162.
8
Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease.纤维化标志物的纵向变化与非酒精性脂肪性肝病患者发生肝硬化和肝细胞癌的风险相关。
J Hepatol. 2023 Mar;78(3):493-500. doi: 10.1016/j.jhep.2022.10.035. Epub 2022 Nov 17.
9
Multicenter validation of FIB-6 as a novel machine learning non-invasive score to rule out liver cirrhosis in biopsy-proven MAFLD.多中心验证 FIB-6 作为一种新的机器学习非侵入性评分，以排除经活检证实的 MAFLD 中的肝硬化。
Eur J Gastroenterol Hepatol. 2023 Nov 1;35(11):1284-1288. doi: 10.1097/MEG.0000000000002641. Epub 2023 Sep 5.
10
Diagnostic performance of non-invasive tests in patients with MetALD in a health check-up cohort.在健康体检队列中，非侵入性检查对 MetALD 患者的诊断性能。
J Hepatol. 2024 Nov;81(5):772-780. doi: 10.1016/j.jhep.2024.05.042. Epub 2024 Jun 13.

引用本文的文献

1
Predictive value of asprosin combined with LAP for metabolic dysfunction associated steatotic liver disease in the physical examination population.体检人群中阿朴脂蛋白与脂蛋白相关磷脂酶A2联合检测对代谢功能障碍相关脂肪性肝病的预测价值
Sci Rep. 2025 Jul 1;15(1):21034. doi: 10.1038/s41598-025-07172-6.
2
Diagnostic Accuracy of the LiverRisk Score to Detect Increased Liver Stiffness Among a United States General Population and Subgroups.肝脏风险评分在美国普通人群及亚组中检测肝脏硬度增加的诊断准确性
J Clin Exp Hepatol. 2025 Jul-Aug;15(4):102512. doi: 10.1016/j.jceh.2025.102512. Epub 2025 Feb 6.
3
Type 2 Diabetes Mellitus in Inflammatory Bowel Disease Patients: A Case-Control Study Through a Long Follow-Up Period.
炎症性肠病患者中的2型糖尿病：一项长期随访的病例对照研究。
J Clin Med. 2024 Dec 30;14(1):143. doi: 10.3390/jcm14010143.
4
Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024).《代谢功能障碍相关脂肪性肝病防治指南（2024年版）》
J Clin Transl Hepatol. 2024 Nov 28;12(11):955-974. doi: 10.14218/JCTH.2024.00311. Epub 2024 Nov 4.
5
The Different Predictive Effects of Multiple Body Fat Indexes on Metabolic Dysfunction-Associated Fatty Liver Disease.多种体脂指数对代谢功能障碍相关脂肪性肝病的不同预测作用。
Diabetes Metab Syndr Obes. 2024 Oct 19;17:3875-3890. doi: 10.2147/DMSO.S469859. eCollection 2024.
6
A Comparative Analysis of Liver Injury Markers in Post-COVID Syndrome among Elderly Patients: A Prospective Study.老年患者新冠后综合征中肝损伤标志物的比较分析：一项前瞻性研究
J Clin Med. 2024 Feb 18;13(4):1149. doi: 10.3390/jcm13041149.
7
Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.系统评价与Meta分析：非酒精性脂肪性肝病患者中C3前体对肝纤维化的诊断准确性
Biomedicines. 2021 Dec 15;9(12):1920. doi: 10.3390/biomedicines9121920.